Joint Filing Agreement

In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the common stock, par value $0.0001 per share, of China Biologic Products, Inc., a Delaware corporation, and that this Agreement may be included as an Exhibit to such joint filing. This Agreement may be executed in any number of counterparts all of which, taken together, shall constitute one and the same instrument.


IDG-ACCEL CHINA GROWTH FUND II L.P. By: IDG-Accel China Growth Fund II Associates L.P., its General Partner By: IDG-Accel China Growth Fund GP II Associates Ltd., its General Partner

By:		/s/ Quan ZHOU
		Name: Quan ZHOU
		Title: Authorized Signatory

IDG-ACCEL CHINA GROWTH FUND II ASSOCIATES L.P. By: IDG-Accel China Growth Fund GP II Associates Ltd., its General Partner

By:		/s/ Quan ZHOU
		Name: Quan ZHOU
		Title: Authorized Signatory

IDG-ACCEL CHINA GROWTH FUND GP II ASSOCIATES LTD.

By:		/s/ Quan ZHOU
		Name: Quan ZHOU
		Title: Authorized Signatory

IDG-ACCEL CHINA INVESTORS II L.P. By: IDG-Accel China Growth Fund GP II Associates Ltd., its General Partner

By:		/s/ Quan ZHOU
		Name: Quan ZHOU
		Title: Authorized Signatory

QUAN ZHOU

By:		/s/ Quan ZHOU

CHI SING HO

By:		/s/ Chi Sing HO


CUSIP No. 16938C106		SCHEDULE 13G		Page 12 of 12 Pages